RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.
While AI offers remarkable efficiency, the pharmaceutical industry must address concerns about “black box” predictions – AI ...
Vietnam Investment Review on MSN9d
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development AcceleratesAIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical ...
Nipah virus, a highly lethal pathogen belonging to the Paramyxovirus family, has caused multiple outbreaks in South and ...
EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...
TechInvention and Belgium-based Quantoom Biosciences have entered a partnership to enhance the local manufacturing of mRNA ...
Dr Sanjay Singh, CEO of Gennova Biopharmaceuticals, said the firm will do preclinical and phase 1 vaccine tests in India, ...
Pune: Emcure Pharmaceuticals Ltd. subsidiary Gennova Biopharmaceuticals Ltd., is advancing the development of a pathbreaking ...
Gennova Biopharmaceuticals Ltd. on Tuesday announced that it is partnering with the Coalition for Epidemic Preparedness Innovations (CEPI), a subsidiary of Emcure Pharmaceuticals Ltd. for the ...
Industry insiders believe that AI is crucial in the mRNA field. Particularly in vaccine design, anticipating future mutation directions often necessitates insights that are impractical to achieve ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback